
    
      Radiation therapy causes many side effects especially oral mucositis. The purpose of this
      Study is to evaluate the efficacy and safety of rhEGF on oral mucositis in patients receiving
      the radiation therapy or the concurrent chemo-radiotherapy. Head and neck cancer patients who
      have a plan to receive a minimum of 50 Gy radiation therapy will be enrolled.
    
  